Recombinase Polymerase Amplification Assay—A Simple, Fast and Cost-Effective Alternative to Real Time PCR for Specific Detection of Feline Herpesvirus-1

Feline herpesvirus 1 (FHV-1), an enveloped dsDNA virus, is one of the major pathogens of feline upper respiratory tract disease (URTD) and ocular disease. Currently, polymerase chain reaction (PCR) remains the gold standard diagnostic tool for FHV-1 infection but is relatively expensive, requires well-equipped laboratories and is not suitable for field tests. Recombinase polymerase amplification (RPA), an isothermal gene amplification technology, has been explored for the molecular diagnosis of infectious diseases. In this study, an exo-RPA assay for FHV-1 detection was developed and validated. Primers targeting specifically the thymidine kinase (TK) gene of FHV-1 were designed. The RPA reaction was performed successfully at 39°C and the results were obtained within 20 min. Using different copy numbers of recombinant plasmid DNA that contains the TK gene as template, we showed the detection limit of exo-RPA was 102 copies DNA/reaction, the same as that of real time PCR. The exo-RPA assay did not cross-detect feline panleukopenia virus, feline calicivirus, bovine herpesvirus-1, pseudorabies virus or chlamydia psittaci, a panel of pathogens important in feline URTD or other viruses in Alphaherpesvirinae, demonstrating high specificity. The assay was validated by testing 120 nasal and ocular conjunctival swabs of cats, and the results were compared with those obtained with real-time PCR. Both assays provided the same testing results in the clinical samples. Compared with real time PCR, the exo-RPA assay uses less-complex equipment that is portable and the reaction is completed much faster. Additionally, commercial RPA reagents in vacuum-sealed pouches can tolerate temperatures up to room temperature for days without loss of activity, suitable for shipment and storage for field tests. Taken together, the exo-RPA assay is a simple, fast and cost-effective alternative to real time PCR, suitable for use in less advanced laboratories and for field detection of FHV-1 infection.

[1]  E. Manzanilla,et al.  Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydophila felis and Mycoplasma felis DNA and associated risk factors in cats in Spain with upper respiratory tract disease, conjunctivitis and/or gingivostomatitis , 2017, Journal of feline medicine and surgery.

[2]  P. Patel,et al.  Recombinase Polymerase Amplification Assay for Rapid Diagnostics of Dengue Infection , 2015, PloS one.

[3]  Li-bing Liu,et al.  Rapid and sensitive detection of canine parvovirus type 2 by recombinase polymerase amplification , 2016, Archives of Virology.

[4]  C. Waldner,et al.  Comparison of polymerase chain reaction tests for diagnosis of feline herpesvirus, Chlamydophila felis, and Mycoplasma spp. infection in cats with ocular disease in Canada. , 2010, The Canadian veterinary journal = La revue veterinaire canadienne.

[5]  E. Thiry,et al.  Feline herpesvirus 1 and feline calicivirus infections in a heterogeneous cat population of a rescue shelter , 2009, Journal of feline medicine and surgery.

[6]  G. Browning,et al.  Differential sensitivity of culture and the polymerase chain reaction for detection of feline herpesvirus 1 in vaccinated and unvaccinated cats , 1997, Archives of Virology.

[7]  C. Fraefel,et al.  Quantification of Feline Herpesvirus 1 DNA in Ocular Fluid Samples of Clinically Diseased Cats by Real-Time TaqMan PCR , 2002, Journal of Clinical Microbiology.

[8]  C. Hart,et al.  A Study of Feline Upper Respiratory Tract Disease with Reference to Prevalence and Risk Factors for Infection with Feline Calicivirus and Feline Herpesvirus , 2000, Journal of feline medicine and surgery.

[9]  Olaf Piepenburg,et al.  Rapid Detection of HIV-1 Proviral DNA for Early Infant Diagnosis Using Recombinase Polymerase Amplification , 2013, mBio.

[10]  F. Hufert,et al.  A new approach for diagnosis of bovine coronavirus using a reverse transcription recombinase polymerase amplification assay , 2013, Journal of Virological Methods.

[11]  J. Reif,et al.  Evaluation of serologic and viral detection methods for diagnosing feline herpesvirus-1 infection in cats with acute respiratory tract or chronic ocular disease. , 1999, Journal of the American Veterinary Medical Association.

[12]  H. Egberink,et al.  Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries , 2005, Veterinary Record.

[13]  B. Sherry,et al.  High sensitivity polymerase chain reaction assay for active and latent feline herpesvirus- infections in domestic cats , 1997, Veterinary Record.

[14]  Olaf Piepenburg,et al.  DNA Detection Using Recombination Proteins , 2006, PLoS biology.

[15]  Shaowen Li,et al.  Isolation and Characterization of Chlamydophila psittaci Isolated from Laying Hens with Cystic Oviducts , 2008, Avian diseases.

[16]  B. Hoffmann,et al.  A Portable Reverse Transcription Recombinase Polymerase Amplification Assay for Rapid Detection of Foot-and-Mouth Disease Virus , 2013, PloS one.

[17]  G. Reubel,et al.  Detection of active and latent feline herpesvirus 1 infections using the polymerase chain reaction , 2005, Archives of Virology.

[18]  J. Stiles.  Feline herpesvirus. , 2000, The Veterinary clinics of North America. Small animal practice.

[19]  D. Whiley,et al.  Sequence variation can affect the performance of minor groove binder TaqMan probes in viral diagnostic assays. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[20]  M. Kiupel,et al.  Ocular and neural distribution of feline herpesvirus-1 during active and latent experimental infection in cats , 2013, BMC Veterinary Research.